Previous close | 27.72 |
Open | 27.67 |
Bid | 27.62 x 1200 |
Ask | 27.64 x 900 |
Day's range | 27.32 - 27.71 |
52-week range | 25.61 - 42.22 |
Volume | |
Avg. volume | 44,601,030 |
Market cap | 156.002B |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | 74.46 |
EPS (TTM) | 0.37 |
Earnings date | 30 Apr 2024 - 06 May 2024 |
Forward dividend & yield | 1.68 (6.06%) |
Ex-dividend date | 25 Jan 2024 |
1y target est | 29.61 |
(Bloomberg) -- Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesTrump Rules Out Vivek Ramaswamy as Running Mate as He Eyes New TeamNvidia Unveils Successor to Its All-Conquering AI ProcessorMusk Says His Ketamine Prescription Is in Investors’ Best InterestsEvergrande’s Alleged $78 Billion
Pfizer previously held a 32% stake, followed by second-largest shareholder GSK which has a 4.2% holding. This is Pfizer's first stake sale in Haleon since the company was spun off from GSK and listed in 2022 - three years after its formation by combining the pharma giants' consumer healthcare units. Pfizer said last year it planned to cut its ownership in a "slow and methodical" manner within months.
In this article, we will take a look at 30 Best Countries to Live in the World. You can skip our detailed analysis and go directly to the 10 Best Countries to Live in the World. According to Maslow’s hierarchy of human needs, we progress through levels of basic needs (food, shelter, clothing, etc.) to […]